Literature DB >> 20032046

Siglec-7 mediates nonapoptotic cell death independently of its immunoreceptor tyrosine-based inhibitory motifs in monocytic cell line U937.

Motoaki Mitsuki1, Kiyomitsu Nara, Toshiyuki Yamaji, Ayako Enomoto, Mayumi Kanno, Yoshiki Yamaguchi, Akane Yamada, Satoshi Waguri, Yasuhiro Hashimoto.   

Abstract

Siglec-7, a sialic acid binding immunoglobulin-like lectin, predominantly transduces inhibitory signals through cytosolic immunoreceptor tyrosine-based inhibitory motifs (ITIMs). Here, we report that clustering of Siglec-7 with a specific F(ab')(2) elicited cell death. Interestingly, a truncated Siglec-7 lacking the cytosolic ITIM domain still induced the cell death, suggesting that the ITIMs are not essential for the death signaling. Further analyses of the death signaling revealed that an oxygen radical scavenger, N-acetyl cysteine, completely inhibited the cell death, whereas a pancaspase inhibitor did not. In addition, caspase-3 activation, DNA ladder formation, and nuclear condensation were not detected during the death process, suggesting that the cell death is nonapoptotic. To identify the critical region for the death signaling, we prepared a series of shuffling chimeras between Siglec-7 and Siglec-9, the latter of which did not transduce a death signal. The critical region was mapped to the middle of the membrane-proximal C2-set domain, which contained only six amino acid differences between Siglec-7 and Siglec-9. Point mutation analyses of each of these six amino acids revealed that four of the six amino acids were critical for the death signal. A computer-assisted 3D modeling revealed that these four amino acids were proximally located on the surface of the C2-set domain. In conclusion, Siglec-7 induces nonapoptotic cell death, the signal for which is transduced by an extracellular C2-set domain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20032046     DOI: 10.1093/glycob/cwp195

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  8 in total

Review 1.  Multifarious roles of sialic acids in immunity.

Authors:  Ajit Varki; Pascal Gagneux
Journal:  Ann N Y Acad Sci       Date:  2012-04       Impact factor: 5.691

Review 2.  Viewing Siglecs through the lens of tumor immunology.

Authors:  Isabella Fraschilla; Shiv Pillai
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

Review 3.  Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense.

Authors:  Kayluz Frias Boligan; Circe Mesa; Luis Enrique Fernandez; Stephan von Gunten
Journal:  Cell Mol Life Sci       Date:  2014-12-07       Impact factor: 9.261

4.  Siglec-7 as a Novel Biomarker to Predict Mortality in Decompensated Cirrhosis and Acute Kidney Injury.

Authors:  Andrew S Allegretti; Guillermo Ortiz; Sahir Kalim; Joshua Wibecan; Dongsheng Zhang; Hui Yi Shan; Dihua Xu; Raymond T Chung; S Ananth Karumanchi; Ravi I Thadhani
Journal:  Dig Dis Sci       Date:  2016-09-21       Impact factor: 3.199

Review 5.  Eosinophil and mast cell Siglecs: From biology to drug target.

Authors:  Jeremy A O'Sullivan; Alan T Chang; Bradford A Youngblood; Bruce S Bochner
Journal:  J Leukoc Biol       Date:  2020-01-22       Impact factor: 4.962

6.  Binding of a sialic acid-recognizing lectin Siglec-9 modulates adhesion dynamics of cancer cells via calpain-mediated protein degradation.

Authors:  Ilhamjan Sabit; Noboru Hashimoto; Yasuyuki Matsumoto; Toshiyuki Yamaji; Keiko Furukawa; Koichi Furukawa
Journal:  J Biol Chem       Date:  2013-10-21       Impact factor: 5.157

7.  Multivalent Interactions of Human Primary Amine Oxidase with the V and C22 Domains of Sialic Acid-Binding Immunoglobulin-Like Lectin-9 Regulate Its Binding and Amine Oxidase Activity.

Authors:  Heli Elovaara; Vimal Parkash; Ruth Fair-Mäkelä; Outi M H Salo-Ahen; Gabriela Guédez; Eva Bligt-Lindén; Janne Grönholm; Sirpa Jalkanen; Tiina A Salminen
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

8.  Siglec-8 Signals Through a Non-Canonical Pathway to Cause Human Eosinophil Death In Vitro.

Authors:  Daniela J Carroll; Yun Cao; Bruce S Bochner; Jeremy A O'Sullivan
Journal:  Front Immunol       Date:  2021-10-11       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.